BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29743640)

  • 1. Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis.
    Cui X; Chang L; Li Y; Lv Q; Wang F; Lin Y; Li W; Meade JD; Walden JC; Liang P
    Sci Rep; 2018 May; 8(1):7327. PubMed ID: 29743640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.
    McCann FE; Perocheau DP; Ruspi G; Blazek K; Davies ML; Feldmann M; Dean JL; Stoop AA; Williams RO
    Arthritis Rheumatol; 2014 Oct; 66(10):2728-38. PubMed ID: 24965881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis.
    Quattrocchi E; Walmsley M; Browne K; Williams RO; Marinova-Mutafchieva L; Buurman W; Butler DM; Feldmann M
    J Immunol; 1999 Jul; 163(2):1000-9. PubMed ID: 10395698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF receptor II fusion protein with tandemly repeated Fc domains.
    Nagashima H; Kaneko K; Yamanoi A; Motoi S; Konakahara S; Kohroki J; Masuho Y
    J Biochem; 2011 Mar; 149(3):337-46. PubMed ID: 21278157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
    Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
    Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recombinant anti-TNF-α fusion protein ameliorates rheumatoid arthritis by the protective role of autophagy.
    Chen X; Nie K; Zhang X; Tan S; Zheng Q; Wang Y; Chen X; Tang Z; Liu R; Yan M; Liu Z; Lin J; Xu J; Zhang N; Wang H; Yang J
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32880389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor (TNF)-soluble high-affinity receptor complex as a TNF antagonist.
    McKenna SD; Feger G; Kelton C; Yang M; Ardissone V; Cirillo R; Vitte PA; Jiang X; Campbell RK
    J Pharmacol Exp Ther; 2007 Aug; 322(2):822-8. PubMed ID: 17495128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB
    J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis.
    Liu X; Zhou H; Huang X; Cui J; Long T; Xu Y; Liu H; Yu R; Zhao R; Luo G; Huang A; Liang JG; Liang P
    J Immunol; 2016 Oct; 197(8):3029-3037. PubMed ID: 27619991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis.
    Zhang L; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang Y; Zhou A; Wei W
    Eur J Pharmacol; 2013 May; 708(1-3):113-23. PubMed ID: 23454555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors.
    Deng GM; Zheng L; Chan FK; Lenardo M
    Nat Med; 2005 Oct; 11(10):1066-72. PubMed ID: 16170321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-arthritis effect of a novel quinazoline derivative through inhibiting production of TNF-α mediated by TNF-α converting enzyme in murine collagen-induced arthritis model.
    Pu Y; Cao D; Xie C; Pei H; Li D; Tang M; Chen L
    Biochem Biophys Res Commun; 2015 Jul; 462(4):288-93. PubMed ID: 25935488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of an enhanced human serum amyloid A (SAA2) promoter-regulated soluble TNF receptor fusion protein for anti-inflammatory gene therapy.
    Rygg M; Uhlar CM; Thorn C; Jensen LE; Gaughan DJ; Varley AW; Munford RS; Göke R; Chen Y; Whitehead AS
    Scand J Immunol; 2001 Jun; 53(6):588-95. PubMed ID: 11422907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants.
    Bloquel C; Bessis N; Boissier MC; Scherman D; Bigey P
    Hum Gene Ther; 2004 Feb; 15(2):189-201. PubMed ID: 14975191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel therapy of murine collagen-induced arthritis with soluble T1/ST2.
    Leung BP; Xu D; Culshaw S; McInnes IB; Liew FY
    J Immunol; 2004 Jul; 173(1):145-50. PubMed ID: 15210768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report.
    Ventura E; Balza E; Borsi L; Tutolo G; Carnemolla B; Castellani P; Zardi L
    BMC Biotechnol; 2011 Nov; 11():104. PubMed ID: 22074550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-acting tumor necrosis factor alpha-binding protein demonstrates activity in both in vitro and in vivo models of endometriosis.
    Altan ZM; Denis D; Kagan D; Grund EM; Palmer SS; Nataraja SG
    J Pharmacol Exp Ther; 2010 Aug; 334(2):460-6. PubMed ID: 20435921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.